Clinical Trials Browser

Phase 2 × Breast Carcinoma In Situ × exemestane × Clear all

NCT02598557 2023-08-22

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

Phase 2 Completed

180 enrolled 46 charts

Breast Carcinoma In Situ, Breast Neoplasms